Carbetocin

Carbetocin

Clinical data
Routes of administration	Intravenous, intramuscular
ATC code	H01BB03 (WHO)
Legal status
Legal status	UK: POM (Prescription only) Not available (U.S.)
Pharmacokinetic data
Bioavailability	80% (IM)
Elimination half-life	40 minutes
Identifiers
IUPAC name (2S)-1-[(3S,6S,9S,12S,15S)-12-[(2S)-butan-2-yl]- 9-(2-carbamoylethyl)-6-(carbamoylmethyl)-15- [(4-hydroxyphenyl)methyl]-16-methyl-5,8,11,14,17- pentaoxo-1-thia-4,7,10,13,16-pentazacycloicosane- 3-carbonyl]-N-[(1S)-1-(carbamoylmethylcarbamoyl)- 3-methyl-butyl]pyrrolidine-2-carboxamide
CAS Number	37025-55-1
PubChem CID	71715
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C45H69N11O12S
Molar mass	988.162 g/mol

WikiDoc Resources for Carbetocin
Articles
Most recent articles on Carbetocin Most cited articles on Carbetocin Review articles on Carbetocin Articles on Carbetocin in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Carbetocin Images of Carbetocin Photos of Carbetocin Podcasts & MP3s on Carbetocin Videos on Carbetocin
Evidence Based Medicine
Cochrane Collaboration on Carbetocin Bandolier on Carbetocin TRIP on Carbetocin
Clinical Trials
Ongoing Trials on Carbetocin at Clinical Trials.gov Trial results on Carbetocin Clinical Trials on Carbetocin at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Carbetocin NICE Guidance on Carbetocin NHS PRODIGY Guidance FDA on Carbetocin CDC on Carbetocin
Books
Books on Carbetocin
News
Carbetocin in the news Be alerted to news on Carbetocin News trends on Carbetocin
Commentary
Blogs on Carbetocin
Definitions
Definitions of Carbetocin
Patient Resources / Community
Patient resources on Carbetocin Discussion groups on Carbetocin Patient Handouts on Carbetocin Directions to Hospitals Treating Carbetocin Risk calculators and risk factors for Carbetocin
Healthcare Provider Resources
Symptoms of Carbetocin Causes & Risk Factors for Carbetocin Diagnostic studies for Carbetocin Treatment of Carbetocin
Continuing Medical Education (CME)
CME Programs on Carbetocin
International
Carbetocin en Espanol Carbetocin en Francais
Business
Carbetocin in the Marketplace Patents on Carbetocin
Experimental / Informatics
List of terms related to Carbetocin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Background

Carbetocin (INN) is a drug used to control postpartum hemorrhage, bleeding after giving birth. It is sold under the trade name Duratocin. It is an analogue of oxytocin, and its action is similar to that of oxytocin; it causes contraction of the uterus.

Carbetocin is available in Canada and the United Kingdom, but not in the United States.

See also

• Childbirth